Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02001155 · ClinicalTrials.gov registry record

Comparing the Effect of the Water Drinking Test on Intraocular Pressure

A clinical trial of Glaucoma, sponsored by Wills Eye.

Completed
Registry status
40
Enrollment target
1
Study location

NCT02001155: Completed study of Glaucoma, sponsored by Wills Eye.

NCT02001155 is a study of Glaucoma that has completed, run by Wills Eye. The registered enrollment target is 40 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02001155, a study of Glaucoma, has completed, sponsored by Wills Eye.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

A test that was common in the 1960's and was used to detect primary open angle glaucoma was the water drinking test (patients drank 1 quart of water to stress the fluid drainage mechanism of the eyes. Intraocular pressure was then measured over the next hour). Recently this test has been demonstrated as a predictor of peak eye pressure during the day. The purpose of this study is to compare the results of the water drinking test between eyes that have undergone trabeculectomy and eyes that have undergone tube shunt surgery.

Primary Outcome

IOP is assessed every 15 minutes for one hour after the water drinking test is complete.

Conditions Studied

Interventions

  • PROCEDURE Water Drinking Test

Study Locations (1)

Pennsylvania

  • Wills Eye Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-07
Est. Completion 2014-07
Wills Eye

59 total trials

What the finished NCT02001155 record still lists

NCT02001155 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Water Drinking Test is the first listed.

NCT02001155 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02001155 about?

NCT02001155 is a clinical study titled "Comparing the Effect of the Water Drinking Test on Intraocular Pressure". A test that was common in the 1960's and was used to detect primary open angle glaucoma was the water drinking test (patients drank 1 quart of water to stress the fluid drainage mechanism of the eyes. Intraocular pressure was then measured over the next hour). Recently this test has been demonstrate...

What is the current status of trial NCT02001155?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-07. Estimated completion is 2014-07.

What conditions does trial NCT02001155 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT02001155?

The interventions under investigation include: Water Drinking Test (PROCEDURE).

Who is sponsoring clinical trial NCT02001155?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02001155 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02001155's enrollment target sits among peer trials

40 74th of 92 higher than 17 of 92 other Glaucoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02001155, the US trial registry maintained by the National Library of Medicine. NCT02001155 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.